Sanofi (SNYN)
Mexican Exchange · Mexico · prices in MXN · close of 23 Oct 2026
Key indicators
| Last close | MXN 773.00 |
|---|---|
| 52-week range | 724.00 – 955.00 |
| Return, 1 month / 3 months | +6.3% / +2.8% |
| Return, 1 year / 3 years | −10.1% / −10.7% |
| Trend | Uptrend |
| RSI (14) | 65 |
| Volatility (1 year) | 25.1% |
| Worst drawdown (1 year) | -21.1% |
| Average daily value traded | 0.05M MXN |
| Dividend yield | 5.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sanofi is a pharmaceutical company based in France that develops and supplies prescription medicines, vaccines and consumer healthcare products. Its treatments address areas such as diabetes, cardiovascular disease, rare diseases and immunology, while its vaccines business provides protection against seasonal influenza and other infections. It also offers over-the-counter health products. Customers include hospitals, doctors, pharmacies and health systems in many countries around the world.
On this site Sanofi appears as a stock on the Mexican Exchange (Mexico), code SNYN, with prices in Mexican pesos (MXN). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sanofi (SNYN) trades on the Mexican Exchange in Mexico. It last closed at MXN 773.00 on 23 October 2026.
Its price-based Market X-Ray is 40 out of 100 (a weak price profile), ranking 270 of 361 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 10.1% and over the last three months it rose 2.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Mexican Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 33 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 0.7% | ||
| From 52-week high | -19.1% | ||
| Momentum | 32 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 2.8% | ||
| 6-month return | -4.9% | ||
| 12-month return, skipping the last month | -15.4% | ||
| Stability (higher is calmer) | 60 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 25.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.1% | ||
| Liquidity | 16 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.05M MXN | ||
| Zero-volume days | 70.0% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.5% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +5.9% |
|---|---|
| 1 month | +6.3% |
| 3 months | +2.8% |
| 6 months | −4.9% |
| 1 year | −10.1% |
| 3 years | −10.7% |
| 5 years | −10.0% |
Signals
| 50-day / 200-day average | 744.24 / 767.44 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.80 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 May 2026 | MXN 42.2216 |
| 9 May 2025 | MXN 31.1431 |
| 9 May 2024 | MXN 24.9667 |
| 30 May 2023 | MXN 24.3283 |
| 26 May 2022 | MXN 3.4961 |
| 4 May 2022 | MXN 25.5038 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Mexican Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.